M.D.C. (NYSE:MDC) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of M.D.C. (NYSE:MDC – Get Rating) in a research report sent to investors on Thursday. The firm issued a hold rating on the construction company’s stock.

A number of other equities research analysts have also issued reports on MDC. JPMorgan Chase & Co. cut their price target on shares of M.D.C. from $30.50 to $27.50 and set an underweight rating on the stock in a report on Monday, March 6th. Wedbush reaffirmed a neutral rating on shares of M.D.C. in a research note on Tuesday, February 7th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the stock. According to MarketBeat, the company currently has an average rating of Hold and a consensus price target of $27.50.

M.D.C. Trading Down 1.0 %

M.D.C. stock traded down $0.38 during trading hours on Thursday, reaching $36.69. The stock had a trading volume of 2,962,994 shares, compared to its average volume of 600,792. The stock has a market cap of $2.68 billion, a PE ratio of 4.78 and a beta of 1.36. M.D.C. has a 52 week low of $27.04 and a 52 week high of $43.88. The company has a debt-to-equity ratio of 0.54, a current ratio of 8.58 and a quick ratio of 2.84. The company has a fifty day simple moving average of $37.06 and a 200-day simple moving average of $32.91.

M.D.C. (NYSE:MDC – Get Rating) last announced its quarterly earnings results on Tuesday, January 31st. The construction company reported $1.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.53 by ($0.45). The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.31 billion. M.D.C. had a return on equity of 19.24% and a net margin of 9.83%. M.D.C.’s revenue was up 3.6% on a year-over-year basis. During the same period last year, the business earned $2.21 EPS. Analysts forecast that M.D.C. will post 2.61 EPS for the current fiscal year.

M.D.C. Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 22nd. Stockholders of record on Wednesday, February 8th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 5.45%. The ex-dividend date was Tuesday, February 7th. M.D.C.’s payout ratio is 26.08%.

Insider Activity

In related news, Director David E. Blackford sold 3,000 shares of the business’s stock in a transaction dated Wednesday, February 8th. The shares were sold at an average price of $38.35, for a total transaction of $115,050.00. Following the sale, the director now owns 25,087 shares of the company’s stock, valued at $962,086.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director David E. Blackford sold 3,000 shares of the business’s stock in a transaction dated Wednesday, February 8th. The shares were sold at an average price of $38.35, for a total transaction of $115,050.00. Following the sale, the director now owns 25,087 shares of the company’s stock, valued at $962,086.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Herbert T. Buchwald sold 8,349 shares of the business’s stock in a transaction dated Wednesday, March 8th. The stock was sold at an average price of $36.20, for a total transaction of $302,233.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,849 shares of company stock valued at $582,299. Corporate insiders own 23.30% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. BNP Paribas Arbitrage SA raised its holdings in M.D.C. by 176.7% in the second quarter. BNP Paribas Arbitrage SA now owns 174,867 shares of the construction company’s stock worth $5,650,000 after buying an additional 111,668 shares during the last quarter. Advisory Research Inc. purchased a new position in M.D.C. in the second quarter worth about $1,734,000. Tudor Investment Corp Et Al raised its holdings in M.D.C. by 1,084.1% in the third quarter. Tudor Investment Corp Et Al now owns 115,424 shares of the construction company’s stock worth $3,165,000 after buying an additional 105,676 shares during the last quarter. Advisors Asset Management Inc. raised its holdings in M.D.C. by 60.3% in the third quarter. Advisors Asset Management Inc. now owns 136,318 shares of the construction company’s stock worth $3,738,000 after buying an additional 51,275 shares during the last quarter. Finally, Quadrant Capital Group LLC raised its holdings in M.D.C. by 217.2% in the third quarter. Quadrant Capital Group LLC now owns 3,055 shares of the construction company’s stock worth $84,000 after buying an additional 2,092 shares during the last quarter. 82.21% of the stock is owned by hedge funds and other institutional investors.

M.D.C. Company Profile

(Get Rating)

M.DC Holdings, Inc engages in proving homebuilding and financial services. It operates through the following business segments: West, Mountain, and East. The West segment includes operations in Arizona, California, Nevada, New Mexico, Oregon, Texas, and Washington. The Mountain segment refers to the operations in Colorado, Idaho, and Utah.